Biotech Values

[Whalatane]

Xavier ...your wife ( on Vascepa ) ...might find this interesting .. A presentation due tomorrow..
Hopefully she is not currently " stented " or in need of a CABG any time soon ....but for those that are ....AMRN's Vascepa is IMHO a very cost effective way to reduce risks of such.

https://scai.confex.com/scai/2020/meetingapp.cgi/Paper/11665

Note Conclusions:

For statin-treated patients with elevated triglycerides and increased cardiovascular risk, icosapent ethyl significantly reduced first and subsequent revascularizations compared with placebo. We are aware of no other non-LDL based therapy in the statin era that has been shown to reduce CABG in a blinded, randomized trial.

Kiwi